Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Cyclophosphamide severely damages the intestinal lining in rats.

Bicalutamide improves hair density in women safely.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

The new compound may be a safer alternative to finasteride for prostate protection.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

Fludalanine failed as an effective oral antibiotic despite efforts.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Topical putrescine and spermine increased DNA synthesis in hairless mouse skin.

A quick method effectively detects banned substances in urine.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.